Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies

European Radiology

Volumn 20, Issue 12, 2010, Pages 2781-2790

  Portalez, Daniel ^a   Rollin, Gautier ^b   Leandri, Pierre ^c   Elman, Benjamin ^a   Mouly, Patrick ^b   Jonca, Frédéric ^b   Malavaud, Bernard ^b  

^a CLINIQUE PASTEUR   (France)

^b CHU RANGUEIL   (France)

^c Clinique Saint Jean Languedoc   (France)

Author keywords

Biopsies; DCE MRI; DWI MRI; Prostate cancer; T2w MRI

Indexed keywords

CHOLINE; CITRIC ACID; CREATINE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CHRONIC PROSTATITIS; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; DIGITAL RECTAL EXAMINATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING; TRANSRECTAL ULTRASONOGRAPHY;

AGED; BIOPSY, NEEDLE; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 78650303595     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-010-1868-6     Document Type: Article

References (38)

1. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics, 2009 CA Cancer J Clin 59 225 249 10.3322/caac.20006 19474385
2. FH Schroder J Hugosson MJ Roobol, et al. 2009 Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 1320 1328 10.1056/NEJMoa0810084 19297566
3. GL Andriole ED Crawford RL Grubb 3rd, et al. 2009 Mortality results from a randomized prostate-cancer screening trial N Engl J Med 360 1310 1319 1:CAS:528:DC%2BD1MXjs1ejsLk%3D 10.1056/NEJMoa0810696 19297565
4. A Heidenreich G Aus M Bolla, et al. 2008 EAU guidelines on prostate cancer Eur Urol 53 68 80 10.1016/j.eururo.2007.09.002 17920184 (Pubitemid 350166735)
5. S Sclaverano G Chevreau L Vadcard P Mozer J Troccaz 2009 BiopSym: a simulator for enhanced learning of ultrasound-guided prostate biopsy Stud Health Technol Inform 142 301 306 19377173
6. MA Levine M Ittman J Melamed H Lepor 1998 Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer J Urol 159 471 475 1:STN:280:DyaK1czhtFGquw%3D%3D 10.1016/S0022-5347(01)63951-X 9649265 Discussion 475-476 (Pubitemid 28049258)
7. B Djavan M Waldert A Zlotta, et al. 2001 Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study J Urol 166 856 860 1:STN:280:DC%2BD3MvksVShtg%3D%3D 10.1016/S0022-5347(05)65851-X 11490233
8. H Hricak PL Choyke SC Eberhardt SA Leibel PT Scardino 2007 Imaging prostate cancer: a multidisciplinary perspective Radiology 243 28 53 10.1148/radiol.2431030580 17392247 (Pubitemid 46579693)
9. SA Reinsberg GS Payne SF Riches, et al. 2007 Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection AJR Am J Roentgenol 188 91 98 10.2214/AJR.05.2198 17179350 (Pubitemid 46012494)
10. R Bammer M Auer SL Keeling, et al. 2002 Diffusion tensor imaging using single-shot SENSE-EPI Magn Reson Med 48 128 136 10.1002/mrm.10184 12111940 (Pubitemid 34721596)
11. JJ Futterer SW Heijmink TW Scheenen, et al. 2006 Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging Radiology 241 449 458 10.1148/radiol.2412051866 16966484 (Pubitemid 44632891)
12. MR Engelbrecht HJ Huisman RJ Laheij, et al. 2003 Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging Radiology 229 248 254 10.1148/radiol. 2291020200 12944607 (Pubitemid 37152132)
13. O Akin E Sala CS Moskowitz, et al. 2006 Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging Radiology 239 784 792 10.1148/radiol.2392050949 16569788
14. JA Jung FV Coakley DB Vigneron, et al. 2004 Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system Radiology 233 701 708 10.1148/radiol.2333030672 15564406
15. AC Westphalen FV Coakley A Qayyum, et al. 2008 Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging Radiology 246 177 184 10.1148/radiol.2453062042 18024434 (Pubitemid 350305041)
16. KL Zakian S Eberhardt H Hricak, et al. 2003 Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging-initial results Radiology 229 241 247 10.1148/radiol.2291021383 12920178 (Pubitemid 37152131)
17. YJ Choi JK Kim N Kim KW Kim EK Choi KS Cho 2007 Functional MR imaging of prostate cancer Radiographics 27 63 75 10.1148/rg.271065078 17234999 Discussion 75-77
18. M Remzi YK Fong M Dobrovits, et al. 2005 The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume J Urol 174 1256 1260 10.1097/01.ju.0000173924. 83392.cc 16145388 Discussion 1260-1251; author reply 1261 (Pubitemid 41318696)
19. RT Vollmer 1996 Multivariate statistical analysis for pathologist. Part I, the logistic model Am J Clin Pathol 105 115 126 1:STN:280: DyaK287ktlCksQ%3D%3D 8561077
20. BK Park HM Lee CK Kim HY Choi JW Park 2008 Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy Invest Radiol 43 789 793 10.1097/RLI. 0b013e318183725e 18923258
21. JC Weinreb JD Blume FV Coakley, et al. 2009 Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy-results of ACRIN prospective multi-institutional clinicopathologic study Radiology 251 122 133 10.1148/radiol.2511080409 19332850
22. A Prando J Kurhanewicz AP Borges EM Oliveira Jr E Figueiredo 2005 Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience Radiology 236 903 910 10.1148/radiol. 2363040615 16118169 (Pubitemid 41170854)
23. GJ Kelloff P Choyke DS Coffey 2009 Challenges in clinical prostate cancer: role of imaging AJR Am J Roentgenol 192 1455 1470 10.2214/AJR.09.2579 19457806
24. HK Lim JK Kim KA Kim KS Cho 2009 Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection-a multireader study Radiology 250 145 151 10.1148/radiol.2501080207 19017927
25. DM Koh DJ Collins 2007 Diffusion-weighted MRI in the body: applications and challenges in oncology AJR Am J Roentgenol 188 1622 1635 10.2214/AJR.06.1403 17515386 (Pubitemid 46866868)
26. D Le Bihan E Breton D Lallemand ML Aubin J Vignaud M Laval-Jeantet 1988 Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging Radiology 168 497 505 3393671
27. B Turkbey PS Albert K Kurdziel PL Choyke 2009 Imaging localized prostate cancer: current approaches and new developments AJR Am J Roentgenol 192 1471 1480 10.2214/AJR.09.2527 19457807
28. K Kitajima Y Kaji K Kuroda K Sugimura 2008 High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio Magn Reson Med Sci 7 93 99 10.2463/mrms.7.93 18603841
29. MA Haider TH van der Kwast J Tanguay, et al. 2007 Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer AJR Am J Roentgenol 189 323 328 10.2214/AJR.07.2211 17646457 (Pubitemid 47195916)
30. DL Langer TH van der Kwast AJ Evans J Trachtenberg BC Wilson MA Haider 2009 Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI J Magn Reson Imaging 30 327 334 10.1002/jmri.21824 19629981
31. Y Mazaheri A Shukla-Dave H Hricak, et al. 2008 Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging-correlation with pathologic findings Radiology 246 480 488 10.1148/radiol.2462070368 18227542
32. RV Mulkern AS Barnes SJ Haker, et al. 2006 Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range Magn Reson Imaging 24 563 568 10.1016/j.mri.2005.12.008 16735177 (Pubitemid 43776563)
33. SF Riches K Hawtin EM Charles-Edwards NM de Souza 2009 Diffusion-weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients NMR Biomed 22 318 325 1:STN:280:DC%2BD1M7psVymtQ%3D%3D 10.1002/nbm.1328 19009566
34. H Shinmoto K Oshio A Tanimoto, et al. 2009 Biexponential apparent diffusion coefficients in prostate cancer Magn Reson Imaging 27 355 359 10.1016/j.mri.2008.07.008 18768281
35. O Rouviere A Raudrant R Ecochard, et al. 2003 Characterization of time-enhancement curves of benign and malignant prostate tissue at dynamic MR imaging Eur Radiol 13 931 942 12695812
36. AB Cheikh N Girouin M Colombel, et al. 2009 Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy Eur Radiol 19 770 778 10.1007/s00330-008-1190-8 18925403
37. FA van Dorsten M van der Graaf MR Engelbrecht, et al. 2004 Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer J Magn Reson Imaging 20 279 287 10.1002/jmri.20113 15269954 (Pubitemid 38970937)
38. P Preziosi A Orlacchio G Di Giambattista, et al. 2003 Enhancement patterns of prostate cancer in dynamic MRI Eur Radiol 13 925 930 12695811